Allergy/Asthma News

Researchers traced childhood illnesses like asthma, frequent head colds and tonsilitis to the development of chronic rhinosinusitis in middle age in a population-based study.

A recent study found that health care professionals were increasingly able to identify infants and young children with anaphylaxis by following modified criteria.

A crossover study revealed that dry powder epinephrine administered via nasal spray yielded drug exposures equal to or higher than those provided by autoinjectors in a canine model.

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended marketing authorization of ARS Pharmaceuticals’ EURneffy epinephrine nasal spray in the European Union, according to a press release.

Recent comments from In-N-Out Burger chain owner and president Lynsi Snyder regarding the company’s inclusion of sesame flour in its buns has sparked concern from leading allergy advocacy organizations and specialists.

A panel of experts agreed that vaccines can be safe and effective in patients receiving dupilumab, although they said that physicians should engage with patients in decision-making before vaccination.

H.R. 3935, a bill signed into law on May 16 by President Joe Biden, includes a clause stating that the Federal Aviation Administration must reconsider medications and protocol for emergency treatment of anaphylaxis on airplanes.

Feeding children peanut products from infancy to age 5 years reduced the prevalence of peanut allergy into adolescence, according to recent data.

Researchers found a significant association between type 2 inflammation and asthma and an increased risk for coronary artery disease.

The use of electronic nicotine delivery systems by adults in the last 30 days was associated with earlier ages of asthma onset, suggesting that public health measures should be taken to motivate users to stop, according to a recent study.